Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Schizophr Res. 2014 Dec 18;161(0):399–402. doi: 10.1016/j.schres.2014.12.002

Table 3.

Group differences in treatment utilization variables

n Intact Neurocognitive Insight
Mean (SD)
Impaired Neurocognitive Insight
Mean (SD)
t df p
CCT attendance (%) 20 52.5 (41.9) 69.1 (42.0) −0.84 18 0.411
Satisfaction (1–10) 10 9.3 (1.0) 8.3 (1.2) 1.44 8 0.187
Mean self-reported strategy use at post-treatment 8 1.8 (0.7) 1.4 (1.0) 0.66 6 0.533